Skip to main content
Caplight Logo









AnalysisMode

AnalysisMode

Private
HelsinkiHealthcare & Life Scienceshttps://analysismode.com/

Last Round

Accelerator

Apr 1, 2021

Company Overview

AnalysisMode is a biotechnology company that provides an AI-powered bioprocess simulation platform called SimCell to help scientists optimize cell culture and biomanufacturing experiments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital twinbioprocess simulationin-silicobiomanufacturingcell culturebiotech softwaredrug developmentbioprocess optimizationexplainable AIXAIvirtual experimentsneuroevolutionbiotech consultancylab automationAI-driven R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AnalysisMode Comparables

Compare AnalysisMode with similar companies based on industry and business-model similarity.

AnalysisMode comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DataHow AG
88%
Novasign GmbH
86%
Algocell
83%

AnalysisMode Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 1, 2021

AnalysisMode Investors

Notable investors and investment history

AnalysisMode investors
InvestorRounds
Health Incubator HelsinkiAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 30, 2024

    Monthly visitors increased 1638% MoM, from 24 to 417.

AnalysisMode Filings

Explore SEC and related filing metadata, where available.

AnalysisMode filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AnalysisMode's valuation, stock price, and market status.

Is AnalysisMode a public or private company?

AnalysisMode is a private company.

What is the current stock price of AnalysisMode?

AnalysisMode is a private company with no public stock price. No recent secondary market data is available.

How much is AnalysisMode worth (valuation)?

Valuation information for AnalysisMode is not publicly available.

Can I buy AnalysisMode stock?

AnalysisMode shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AnalysisMode's last funding round?

AnalysisMode's most recent funding round was Accelerator on April 1, 2021.

Who are the main investors in AnalysisMode?

Key investors in AnalysisMode include Health Incubator Helsinki.

Will AnalysisMode IPO soon?

No public IPO plans have been announced for AnalysisMode.

How can I track AnalysisMode secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AnalysisMode's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHelsinki
Employee Range2
Year Founded2017
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?